Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for kidney protection in cooled neonates with hypoxic ischemic encephalopathy
PACTR202409893805769Not yet recruiting
- Sponsor
- Dr. Stella Kangethe
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of aminophylline in hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Dr. Stella Kangethe. Primary endpoint: Effect of aminophylline on kidney functions. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
aminophylline
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on PACTR202409893805769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409893805769.